Chronic pancreatitis is a complex disease that involves many factors, both genetic and 31 environmental. Over the past two decades, molecular genetic analysis of five genes that are highly 32 expressed in human pancreatic acinar cells, namely PRSS1, PRSS2, SPINK1, CTRC and 33 CTRB1/CTRB2, has established that a trypsin-dependent pathway plays a key role in the etiology 34 of chronic pancreatitis. Since Ca 2+ deregulation can lead to intracellular trypsin activation in 35 experimental acute pancreatitis, we analyzed STIM1 (encoding stromal interaction molecule-1, the 36 main regulator of Ca 2+ homeostasis in pancreatic acinar cells) as a candidate modifier gene in 37
INTRODUCTION 47
Chronic pancreatitis is a complex disease that is defined as "a pathologic fibro-inflammatory 48 syndrome of the pancreas in individuals with genetic, environmental and/or other risk factors who 49 develop persistent pathologic responses to parenchymal injury or stress" (Whitcomb et al., 2016) . 50
Over the past two decades, molecular genetic analysis of five genes that are highly expressed in 51 human pancreatic acinar cells, namely PRSS1 encoding cationic trypsinogen (Le Maréchal et al., 52 2006; Whitcomb et al., 1996) , PRSS2 encoding anionic trypsinogen (Witt et al., 2006) , SPINK1 53 encoding pancreatic secretory trypsin inhibitor (Witt et al., 2000) , CTRC encoding chymotrypsin C 54 (Masson et al., 2008; Rosendahl et al., 2008) and CTRB1-CTRB2 encoding chymotrypsin B1 and 55 B2 (Rosendahl et al., 2018) , has established a trypsin-dependent pathway in the etiology of chronic 56 pancreatitis (Hegyi and Sahin-Toth, 2017) . 57
The majority of patients with chronic pancreatitis had prior clinically recognized acute 58 pancreatitis (LaRusch et al., 2015) , an acute inflammatory disease of the pancreas postulated to be 59 an autodigestive disease triggered by prematurely activated trypsin within the pancreas (Chiari, 60 1896) . The association of gain-of-function PRSS1 variants with both recurrent acute pancreatitis 61 and chronic pancreatitis (Gorry et al., 1997; Whitcomb et al., 1996) not only provided support for 62
Chiari's original hypothesis (Chiari, 1896) but has also contributed to the Sentinel Acute Importantly, successive developments of spontaneous acute pancreatitis and chronic pancreatitis 65 have recently been observed in genetically modified mice that carried a heterozygous p.Asp23Ala 66 mutation within the activation peptide of the mouse cationic trypsinogen (Prss1) T7 isoform (the 67 p.Asp23Ala mutant autoactivates to trypsin 50-fold faster than wild-type) (Geisz and Sahin-Tóth, 68 2018) . 69
The above notwithstanding, our understanding of the early events leading to pancreatitis is still 70 rather limited. In this regard, prolonged and global Ca 2+ elevation (elicited by bile, alcohol 71 metabolites and other causes) has been described to result in trypsin activation, vacuolization and 72 necrosis of the pancreatic acinar cells in experimental acute pancreatitis (review in (Li et al., 2014) ); 73 and stromal interaction molecule-1 (STIM1) is a key regulator for Ca 2+ homeostasis in both non-74 excitable and excitable cells (Yuan et al., 2009 ). These findings suggest that variants in the STIM1 75 gene may contribute to the early steps of pancreatitis by disturbing Ca 2+ homeostasis within the 76 pancreatic tissue. 77
Variants in the STIM1 gene have been previously associated a number of diseases such as 78 immunodeficiency and autoimmunity (Picard et al., 2009; Shaw et al., 2013) , a novel syndrome of 79 amelogenesis imperfecta and hypohidrosis (Parry et al., 2016) , tubular-aggregate myopathy (Bohm 80 et al., 2013; Nesin et al., 2014; Noury et al., 2017) , or Stormorken syndrome (Misceo et al., 2014; 81 Morin et al., 2014) . Also, tubular aggregate myopathy and Stormorken syndrome patients carrying 82 STIM1 variants additionally manifested psychiatric disorders (Harris et al., 2017) . Moreover, Sofia 83 and colleagues have recently analyzed the STIM1 gene (included within a panel of 70 genes 84 related to six different pancreatic pathways) in 80 patients with idiopathic chronic pancreatitis (ICP) 85 and found three missense mutations [i.e., c.1310G>A (p.Cys437Tyr), c.1589G>A (p.Arg530His), 86 and c.2246G>A (p.Arg749His)] in different patients (Sofia et al., 2016) . In addition to the relatively 87 small number of patients analyzed, this study was limited by the lack of data from a corresponding 88 control population. Herein, we report our findings from a comprehensive variant analysis of the 89 STIM1 gene in three ICP cohorts. 90
91

PATIENTS AND METHODS 92
Patients 93
This study included 436 French, 517 German and 1,104 Chinese patients with ICP (i.e., absence of 94 both a positive family history and any of the following external precipitating factors, namely alcohol 95 abuse, post-traumatic, hypercalcemic, hyperlipidemic and autoimmune) and corresponding healthy 96 controls. The diagnosis of chronic pancreatitis was made as previously described (Witt et al., 2013; 97 Zou et al., 2016) . Informed consent was obtained from each patient and the study was approved by 98 the respective ethics committees. 99
Variant screening 100
The French and German subjects were analyzed by Sanger sequencing; three multiplex PCRs 101 were designed to amplify the entire coding sequence and flanking intronic sequences of the STIM1 102 gene (see additional file, Figures. S1 and S2). The Chinese subjects were analyzed by targeted 103 next-generation sequencing followed by Sanger sequencing confirmation, essentially as previously 104 described (Wu et al., 2017; Zou et al., 2018) , the primer sequences are provided in Additional file, 105 Figure S3 . 
Statistical analyses 118
The assessment of statistical significance of the differences between the carrier frequencies of the 119 STIM1 variants in patients and controls was performed by the 2x2 contingency table available at 120 http://vassarstats.net/odds2x2.html. The difference was considered as being statistically significant 121 when the P value was ≤ 0.05. 122
123
RESULTS AND DISCUSSION 124
Given the importance of Ca 2+ signaling for the regulation of pancreatic zymogen activation and the 125 key role of STIM1 in Ca 2+ homeostasis, we analyzed the STIM1 gene as a candidate modifier gene 126 for chronic pancreatitis. Employing Sanger sequencing, we first analyzed the entire coding 127 sequence (2,058 bp; NM_003156.3) and exon/intron boundaries of the 12-exon STIM1 gene in 436 128
French ICP patients and 1,005 controls, and then repeated this analysis with 517 German ICP 129 patients and 1,121 controls. Our subsequent analysis was limited to coding sequence variants that 130 resulted in amino acid changes and intronic variants that affected canonical donor/acceptor splice 131 sites. Eight such variants were identified in the French cohort and ten in the German cohort; all 132 these variants were single nucleotide substitutions and all were predicted to result in missense 133 substitutions (Additional file, Tables S1 and S2). Since all detected variants were rare variants (defined as having a minor allele frequency of <0.5% in the control population as previously 135 described (Manolio et al., 2009; Tennessen et al., 2012) , we first performed aggregate association 136 analysis in the context of each cohort. A significant enrichment of rare variants in patients as 137 compared to controls was noted in the French cohort (odds ratio (OR) = 4.04, P = 0.002) but not in 138 the German cohort (OR = 1.64, P = 0.26) (Table 1) . 139
We also analyzed the STIM1 gene in 1,104 Chinese ICP patients and 1,196 controls by means 140 of targeted sequencing followed by Sanger sequencing validation. A total of 24 rare variants were 141 identified (Additional file, Table S3 ), which when taken together were significantly overrepresented 142 in patients as compared to controls (OR = 2.03, P = 0.03; Table 1 ). A Breslow-Day test for 143 homogeneity of the ORs (https://www.prostatservices.com/) between the French, German and 144
Chinese cohorts showed no significant difference (P = 0.14). We therefore combined data from 145 these three cohorts (Table 2) , the carrier frequency of the aggregated rare variants being 146 significantly higher in patients than in controls (OR = 2.33, P = 0.0001; Table 1 ). 147
Our comprehensive analysis of the STIM1 gene in three ICP cohorts identified a significant 148 enrichment of rare coding STIM1 variants in patients as compared to controls by means of 149 aggregate association analysis (Table 1) . Notably, none of the identified 37 rare STIM1 variants 150 correspond to those previously reported to cause or predispose to other diseases (Lacruz and 151 Feske, 2015) , potentially strengthening the notion of the tissue-specific effects of different STIM1 152 variants. However, pathogenicity prediction by means of the CADD method yielded similar findings 153 among the three groups of variants namely, (i) variants found in only patients, (ii) variants found in 154 both patients and controls and (iii) variants found in only controls (Table 2) . 155
In summary, this is the first large case-control study to demonstrate a putative association of 156 rare STIM1 coding variants with chronic pancreatitis. Functional analysis will be required to clarify 157 whether or not rare coding STIM1 variants predispose to pancreatitis. 158 159
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